Quest Diagnostics Incorporated · NYSE:DGX
Samad Sam received 108 Quest Diagnostics Incorporated shares as an award (Form 4)
Traded Apr 20, 2026 · Filed Apr 24, 2026
On Apr 20, 2026, Samad Sam (Executive Vice President & CFO) received 108 Quest Diagnostics Incorporated shares as an award at US$194.70 for US$21,028, leaving 33,376 shares. Filed Apr 24, 2026 (Form 4).
- Awarded
- 108 shares
- Price
- US$194.70
- Value
- US$21,028
- Holding after
- 33,376 shares
- Trading plan
- No
- Role
- Executive Vice President & CFO
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Apr 20, 2026 | Common Stock | Award | 108 | US$194.70 | 33,376 | Direct |
Source
Related
- Quest Diagnostics Incorporated
- Samad Sam
- Quest Diagnostics Incorporated shareholders
- Form 4 · Samad Sam · Jul 27, 2026
- Form 4 · Davis J. E. · Sep 3, 2026
- Form 4 · Prevoznik Michael E · Aug 31, 2026
- Schedule 13G/A · T. Rowe Price Associates Inc · Aug 14, 2026
- Form 4 · Delaney Mark E · Jul 29, 2026
- Form 4 · Kuppusamy Karthik · Jul 27, 2026